Dossier
deafness
Coverage of deafness in the Nexus archive.
- The FDA gives the green light to the first gene therapy for deafness
The FDA has approved the first gene therapy for deafness, developed by Regeneron Pharmaceuticals, marking a significant medical milestone for treating a rare form of the condition.